Lisata Therapeutics

LSTANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.319 M

$1.70 -2.30%

Close of 18 Sept 2026

Revenue

$170.0K

#3577 by revenue

Earnings

-$16.6M

Loss-making

Shares outstanding

9,010,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#408Tempest TherapeuticsTPST$16.0M
#409Dare BioscienceDARE$15.4M
#410Lisata TherapeuticsLSTA$15.3M
#411Moleculin BiotechMBRX$15.1M
#412VyomeHIND$14.7M

What if Lisata Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$3,372,286

Per share 1,983,698× higher

Bitcoin $1.64T

$181,560.24

Per share 106,800× higher

Nvidia $5.36T

$594,467.25

Per share 349,687× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Lisata Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.